메뉴 건너뛰기




Volumn 7, Issue 4, 2007, Pages 264-269

C1-inhibitor deficiencies (hereditary angioedema): Where are we with therapies?

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; AMINOCAPROIC ACID; ANDROGEN; ANTIFIBRINOLYTIC AGENT; BRADYKININ; COMPLEMENT COMPONENT C1; COMPLEMENT COMPONENT C1S INHIBITOR; DANAZOL; DX 88; ECCALLANTIDE; FLUOXYMESTERONE; FRESH FROZEN PLASMA; ICATIBANT; KALLIKREIN; KALLIKREIN INHIBITOR; METHYLTESTOSTERONE; OXYMETHOLONE; PLACEBO; PREKALLIKREIN; RECOMBINANT COMPLEMENT COMPONENT C1S INHIBITOR; RITUXIMAB; STANOZOLOL; TRANEXAMIC ACID; UNCLASSIFIED DRUG;

EID: 34250708860     PISSN: 15297322     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11882-007-0039-6     Document Type: Review
Times cited : (15)

References (52)
  • 1
    • 0001024770 scopus 로고
    • Hereditary angioneurotic oedema
    • Osler W: Hereditary angioneurotic oedema. Am J Med Sci 1888, 95:362-367.
    • (1888) Am J Med Sci , vol.95 , pp. 362-367
    • Osler, W.1
  • 2
    • 50549190821 scopus 로고
    • A biochemical abnormality in hereditary angioneurotic edema: Absence of serum inhibitor of C'1-esterase
    • Donaldson VH, Evans RR: A biochemical abnormality in hereditary angioneurotic edema: absence of serum inhibitor of C'1-esterase. Am J Med 1963, 35:37-44.
    • (1963) Am J Med , vol.35 , pp. 37-44
    • Donaldson, V.H.1    Evans, R.R.2
  • 3
    • 0019966597 scopus 로고
    • Hereditary angioedema: An appraisal of 104 cases
    • Cicardi M, Bergamaschini L, Marasini B, et al.: Hereditary angioedema: an appraisal of 104 cases. Am J Med Sci 1982, 284:2-9.
    • (1982) Am J Med Sci , vol.284 , pp. 2-9
    • Cicardi, M.1    Bergamaschini, L.2    Marasini, B.3
  • 4
    • 0036212766 scopus 로고    scopus 로고
    • Current management of hereditary angiooedema (C'1 esterase inhibitor deficiency)
    • Fay A, Abinun M: Current management of hereditary angiooedema (C'1 esterase inhibitor deficiency). J Clin Pathol 2002, 55:266-270.
    • (2002) J Clin Pathol , vol.55 , pp. 266-270
    • Fay, A.1    Abinun, M.2
  • 5
    • 0031712910 scopus 로고    scopus 로고
    • Molecular genetics of C'1-inhibitor
    • Tosi M: Molecular genetics of C'1-inhibitor. Immunobiology 1998, 199:358-365.
    • (1998) Immunobiology , vol.199 , pp. 358-365
    • Tosi, M.1
  • 6
    • 0031664687 scopus 로고    scopus 로고
    • Pathogenetic and clinical aspects of C1 inhibitor deficiency
    • Cicardi M, Bergamaschini L, Cugno M, et al.: Pathogenetic and clinical aspects of C1 inhibitor deficiency. Immunobiology 1998, 199:366-376.
    • (1998) Immunobiology , vol.199 , pp. 366-376
    • Cicardi, M.1    Bergamaschini, L.2    Cugno, M.3
  • 8
    • 0031692666 scopus 로고    scopus 로고
    • Regulation of C'1-inhibitor synthesis
    • Prada AE, Zahedi K, Davis AE: Regulation of C'1-inhibitor synthesis. Immunobiology 1998, 199:377-388.
    • (1998) Immunobiology , vol.199 , pp. 377-388
    • Prada, A.E.1    Zahedi, K.2    Davis, A.E.3
  • 9
    • 0034661804 scopus 로고    scopus 로고
    • Hereditary angioedema with normal C1-inhibitor activity in women
    • Bork K, Barnstedt S, Koch P, Traupe H: Hereditary angioedema with normal C1-inhibitor activity in women. Lancet 2000, 356:213-217.
    • (2000) Lancet , vol.356 , pp. 213-217
    • Bork, K.1    Barnstedt, S.2    Koch, P.3    Traupe, H.4
  • 10
    • 33748149553 scopus 로고    scopus 로고
    • The therapeutic potential of a kallikrein inhibitor for treating hereditary angioedema
    • Levy JH, O'Donnell PS: The therapeutic potential of a kallikrein inhibitor for treating hereditary angioedema. Expert Opin Investig Drugs 2006, 19:1077-1090.
    • (2006) Expert Opin Investig Drugs , vol.19 , pp. 1077-1090
    • Levy, J.H.1    O'Donnell, P.S.2
  • 12
    • 0028909546 scopus 로고
    • Unique C1 inhibitor dysfunction in a kindred without angioedema, II. Identification of an Ala443→Val substitution and functional analysis of the recombinant mutant protein
    • Zahedi R, Bissler JJ, Davis AE, et al.: Unique C1 inhibitor dysfunction in a kindred without angioedema, II. Identification of an Ala443→Val substitution and functional analysis of the recombinant mutant protein. J Clin Invest 1995, 95:1299-1305.
    • (1995) J Clin Invest , vol.95 , pp. 1299-1305
    • Zahedi, R.1    Bissler, J.J.2    Davis, A.E.3
  • 13
    • 0031570956 scopus 로고    scopus 로고
    • Role of the P2 residue of complement 1 inhibitor (Ala443) in determination of target protease specificity: Inhibition of complement and contact system proteases
    • Zahedi R, Wisnieski J, Davis AE: Role of the P2 residue of complement 1 inhibitor (Ala443) in determination of target protease specificity: inhibition of complement and contact system proteases. J Immunol 1997, 159:983-988.
    • (1997) J Immunol , vol.159 , pp. 983-988
    • Zahedi, R.1    Wisnieski, J.2    Davis, A.E.3
  • 14
    • 21344434308 scopus 로고    scopus 로고
    • C1 inhibitor deficiency: Consensus document
    • Gompels MM, Lock RJ, Abinun M, et al.: C1 inhibitor deficiency: consensus document. Clin Exp Immunol 2005, 141:189-190.
    • (2005) Clin Exp Immunol , vol.141 , pp. 189-190
    • Gompels, M.M.1    Lock, R.J.2    Abinun, M.3
  • 16
    • 27144463432 scopus 로고    scopus 로고
    • C1 inhibitor deficiency: Management
    • Gompels MM, Lock RJ: C1 inhibitor deficiency: management. Clin Exp Dermatol 2005, 30:737-740.
    • (2005) Clin Exp Dermatol , vol.30 , pp. 737-740
    • Gompels, M.M.1    Lock, R.J.2
  • 17
    • 0017077229 scopus 로고
    • Hereditary angioedema: The clinical syndrome and its management
    • Frank MM, Gelfand JA, Atkinson JP: Hereditary angioedema: the clinical syndrome and its management. Ann Intern Med 1976, 84:580-593.
    • (1976) Ann Intern Med , vol.84 , pp. 580-593
    • Frank, M.M.1    Gelfand, J.A.2    Atkinson, J.P.3
  • 18
    • 0031041933 scopus 로고    scopus 로고
    • Side effects of long-term prophylaxis with attenuated androgens in hereditary angioedema: Comparison of treated and untreated patients
    • Cicardi M, Castelli R, Zingale LC, Agostoni A: Side effects of long-term prophylaxis with attenuated androgens in hereditary angioedema: comparison of treated and untreated patients. J Allergy Clin Immunol 1997, 99:194-196.
    • (1997) J Allergy Clin Immunol , vol.99 , pp. 194-196
    • Cicardi, M.1    Castelli, R.2    Zingale, L.C.3    Agostoni, A.4
  • 19
    • 0033608834 scopus 로고    scopus 로고
    • Hepatocelluar adenomas in patients taking danazol for hereditary angiooedema
    • Bork K, Pitton M, Harten P, Koch P: Hepatocelluar adenomas in patients taking danazol for hereditary angiooedema. Lancet 1999, 353:1066-1067.
    • (1999) Lancet , vol.353 , pp. 1066-1067
    • Bork, K.1    Pitton, M.2    Harten, P.3    Koch, P.4
  • 20
    • 16244384459 scopus 로고    scopus 로고
    • Adverse effects of danazol prophylaxis on the lipid profiles of patients with hereditary angioedema
    • Széplaki G, Varga L, Valentin S, et al.: Adverse effects of danazol prophylaxis on the lipid profiles of patients with hereditary angioedema. J Allergy Clin Immunol 2005, 115:864-869.
    • (2005) J Allergy Clin Immunol , vol.115 , pp. 864-869
    • Széplaki, G.1    Varga, L.2    Valentin, S.3
  • 21
    • 0038161137 scopus 로고    scopus 로고
    • Autoantibodies and lymphoproliferative diseases in acquired C1-inhibitor deficiencies
    • Cicardi M, Zingale LC, Pappalardo E, et al.: Autoantibodies and lymphoproliferative diseases in acquired C1-inhibitor deficiencies. Medicine (Baltimore) 2003, 82:274-281.
    • (2003) Medicine (Baltimore) , vol.82 , pp. 274-281
    • Cicardi, M.1    Zingale, L.C.2    Pappalardo, E.3
  • 23
    • 0015504576 scopus 로고
    • Epsilon aminocaproic acid therapy of hereditary angioneurotic edema: A double blind study
    • Frank MM, Sergent JS, Kane MA, Alling DW: Epsilon aminocaproic acid therapy of hereditary angioneurotic edema: a double blind study. N Engl J Med 1972, 286:808-812.
    • (1972) N Engl J Med , vol.286 , pp. 808-812
    • Frank, M.M.1    Sergent, J.S.2    Kane, M.A.3    Alling, D.W.4
  • 24
    • 0142138728 scopus 로고    scopus 로고
    • How do we treat patients with hereditary angioedema?
    • Cicardi M, Zingale L: How do we treat patients with hereditary angioedema? Transfus Apheresis Sci 2003, 29:221-227.
    • (2003) Transfus Apheresis Sci , vol.29 , pp. 221-227
    • Cicardi, M.1    Zingale, L.2
  • 25
    • 0027317815 scopus 로고
    • Treatment with tranexamic acid during pregnancy, and the risk of thrombo-embolic complications
    • Lindoff C, Rybo G, Astedt B: Treatment with tranexamic acid during pregnancy, and the risk of thrombo-embolic complications. Thromb Haemost 1993, 70:238-240.
    • (1993) Thromb Haemost , vol.70 , pp. 238-240
    • Lindoff, C.1    Rybo, G.2    Astedt, B.3
  • 26
    • 9644268117 scopus 로고    scopus 로고
    • Use of recombinant plasma kallikrein inhibitor in hereditary angioedema: A case report and review of the management of the disorder
    • Turner MD, Oughbourli A, Haeney K, Selvaggi T: Use of recombinant plasma kallikrein inhibitor in hereditary angioedema: a case report and review of the management of the disorder. J Oral Maxillofac Surg 2004, 62:1553-1556.
    • (2004) J Oral Maxillofac Surg , vol.62 , pp. 1553-1556
    • Turner, M.D.1    Oughbourli, A.2    Haeney, K.3    Selvaggi, T.4
  • 27
    • 27144499228 scopus 로고    scopus 로고
    • Emergency treatment of acute attacks in hereditary angioedema due to C1 inhibitor deficiency: What is the evidence?
    • Longhurst HJ: Emergency treatment of acute attacks in hereditary angioedema due to C1 inhibitor deficiency: what is the evidence? Int J Clin Pract 2005, 59:594-599.
    • (2005) Int J Clin Pract , vol.59 , pp. 594-599
    • Longhurst, H.J.1
  • 28
    • 4444318527 scopus 로고    scopus 로고
    • Hereditary angioedema: A half century of progress
    • Frank MM: Hereditary angioedema: a half century of progress. J Allergy Clin Immunol 2004, 114:626-628.
    • (2004) J Allergy Clin Immunol , vol.114 , pp. 626-628
    • Frank, M.M.1
  • 29
    • 0029973831 scopus 로고    scopus 로고
    • Treatment of hereditary angioedema with a vapor-heated C1 inhibitor concentrate
    • Waytes AT, Rosen FS, Frank MM: Treatment of hereditary angioedema with a vapor-heated C1 inhibitor concentrate. N Engl J Med 1996, 334:1630-1634.
    • (1996) N Engl J Med , vol.334 , pp. 1630-1634
    • Waytes, A.T.1    Rosen, F.S.2    Frank, M.M.3
  • 30
    • 0031820676 scopus 로고    scopus 로고
    • A randomized, controlled trial to study the efficacy and safety of C1 inhibitor concentrate in treating hereditary angioedema
    • Kunschak M, Engl W, Maritsch F, et al.: A randomized, controlled trial to study the efficacy and safety of C1 inhibitor concentrate in treating hereditary angioedema. Transfusion 1998, 38:540-549.
    • (1998) Transfusion , vol.38 , pp. 540-549
    • Kunschak, M.1    Engl, W.2    Maritsch, F.3
  • 31
    • 32844457999 scopus 로고    scopus 로고
    • Treatment with C1 inhibitor concentrate in abdominal pain attacks of patients with hereditary angioedema
    • Bork K, Meng G, Staubach P, Hardt J: Treatment with C1 inhibitor concentrate in abdominal pain attacks of patients with hereditary angioedema. Transfusion 2005, 45:1774-1784.
    • (2005) Transfusion , vol.45 , pp. 1774-1784
    • Bork, K.1    Meng, G.2    Staubach, P.3    Hardt, J.4
  • 32
    • 33646022921 scopus 로고    scopus 로고
    • Self-administration of C1-inhibitor concentrate in patients with hereditary and acquired angioedema caused by C1-inhibitor deficiency
    • Levi M, Choi G, Picavet MA, Hack CE: Self-administration of C1-inhibitor concentrate in patients with hereditary and acquired angioedema caused by C1-inhibitor deficiency. J Allergy Clin Immunol 2006, 117:904-908.
    • (2006) J Allergy Clin Immunol , vol.117 , pp. 904-908
    • Levi, M.1    Choi, G.2    Picavet, M.A.3    Hack, C.E.4
  • 33
    • 0142245455 scopus 로고    scopus 로고
    • Safety and efficacy of pasteurized C1 inhibitor concentrate (Berinert P) in hereditary angioedema: A review
    • De Serres J, Groner A, Lindner J: Safety and efficacy of pasteurized C1 inhibitor concentrate (Berinert P) in hereditary angioedema: a review. Transfus Apheresis Sci 2003, 29:247-254.
    • (2003) Transfus Apheresis Sci , vol.29 , pp. 247-254
    • De Serres, J.1    Groner, A.2    Lindner, J.3
  • 34
    • 33748984029 scopus 로고    scopus 로고
    • Hereditary angioedema managed with low-dose danazol and c1 esterase inhibitor concentrate: A case report
    • Altman AD, McLaughlin J, Schellenberg R, et al.: Hereditary angioedema managed with low-dose danazol and c1 esterase inhibitor concentrate: a case report. J Obstet Gynaecol Can 2006, 28:27-31.
    • (2006) J Obstet Gynaecol Can , vol.28 , pp. 27-31
    • Altman, A.D.1    McLaughlin, J.2    Schellenberg, R.3
  • 36
    • 25844432828 scopus 로고    scopus 로고
    • A phase I study of recombinant human C1 inhibitor in asymptomatic patients with hereditary angioedema
    • van Doorn MB, Burggraaf J, Van Dam T, et al.: A phase I study of recombinant human C1 inhibitor in asymptomatic patients with hereditary angioedema. J Allergy Clin Immunol 2005, 116:876-883.
    • (2005) J Allergy Clin Immunol , vol.116 , pp. 876-883
    • van Doorn, M.B.1    Burggraaf, J.2    Van Dam, T.3
  • 37
    • 33644820176 scopus 로고    scopus 로고
    • Recombinant human C1-inhibitor is effective in the treatment of acute attacks of hereditary angioedema - case report [in Polish]
    • Porebski G, Bilo B, Obtulowicz K, et al.: Recombinant human C1-inhibitor is effective in the treatment of acute attacks of hereditary angioedema - case report [in Polish]. Przegl Lek 2005, 62:317-320.
    • (2005) Przegl Lek , vol.62 , pp. 317-320
    • Porebski, G.1    Bilo, B.2    Obtulowicz, K.3
  • 39
    • 0032707505 scopus 로고    scopus 로고
    • A vote for inhaled adrenaline in the treatment of severe upper airway obstruction caused by piercing of the tongue in hereditary angioedema
    • Trachsel D, Hammer J: A vote for inhaled adrenaline in the treatment of severe upper airway obstruction caused by piercing of the tongue in hereditary angioedema. Intensive Care Med 1999, 25:1335-1336.
    • (1999) Intensive Care Med , vol.25 , pp. 1335-1336
    • Trachsel, D.1    Hammer, J.2
  • 40
    • 0142169427 scopus 로고    scopus 로고
    • DX-88 and HAE: A developmental perspective
    • Williams A, Baird LG: DX-88 and HAE: a developmental perspective. Transfus Apheresis Sci 2003, 29:255-258.
    • (2003) Transfus Apheresis Sci , vol.29 , pp. 255-258
    • Williams, A.1    Baird, L.G.2
  • 41
    • 31944445695 scopus 로고    scopus 로고
    • DX-88 a recombinant inhibitor of human plasma kallikrein: Efficacy and safety in hereditary and acquired angioedema
    • Cicardi M, González-Quivedo T, Caballero T, et al.: DX-88 a recombinant inhibitor of human plasma kallikrein: efficacy and safety in hereditary and acquired angioedema. Mol Immunol 2003, 40:197-198.
    • (2003) Mol Immunol , vol.40 , pp. 197-198
    • Cicardi, M.1    González-Quivedo, T.2    Caballero, T.3
  • 42
    • 31944437279 scopus 로고    scopus 로고
    • Anaphylactic reaction and antibodies to DX-88 (kallikrein inhibitor) in a patient with hereditary angioedema
    • Caballero T, López-Serrano C: Anaphylactic reaction and antibodies to DX-88 (kallikrein inhibitor) in a patient with hereditary angioedema. J Allergy Clin Immunol 2006, 117:476-477.
    • (2006) J Allergy Clin Immunol , vol.117 , pp. 476-477
    • Caballero, T.1    López-Serrano, C.2
  • 43
    • 0032490360 scopus 로고    scopus 로고
    • Plasma bradykinin in angio-oedema
    • Nussberger J, Cugno M, Amstutz C, et al.: Plasma bradykinin in angio-oedema. Lancet 1998, 351:1693-1697.
    • (1998) Lancet , vol.351 , pp. 1693-1697
    • Nussberger, J.1    Cugno, M.2    Amstutz, C.3
  • 44
    • 33644773297 scopus 로고    scopus 로고
    • Current treatment of HAE and future treatment options
    • Bork K: Current treatment of HAE and future treatment options. J Allergy Clin Immunol 2007, 113:S94-S96.
    • (2007) J Allergy Clin Immunol , vol.113
    • Bork, K.1
  • 45
    • 33750526677 scopus 로고    scopus 로고
    • Novel pharmacotherapy of acute hereditary angioedema with bradykinin B2-receptor antagonist icatibant
    • Bas M, Bier H, Greve J, et al.: Novel pharmacotherapy of acute hereditary angioedema with bradykinin B2-receptor antagonist icatibant. Allergy 2006, 61:1490-1492.
    • (2006) Allergy , vol.61 , pp. 1490-1492
    • Bas, M.1    Bier, H.2    Greve, J.3
  • 46
    • 31544445804 scopus 로고    scopus 로고
    • B-cell targeted therapies in rheumatoid arthritis and systemic lupus erythematosus
    • Eisenberg R, Albert D: B-cell targeted therapies in rheumatoid arthritis and systemic lupus erythematosus. Nat Clin Pract Rheumatol 2006, 2:20-27.
    • (2006) Nat Clin Pract Rheumatol , vol.2 , pp. 20-27
    • Eisenberg, R.1    Albert, D.2
  • 47
    • 28944435507 scopus 로고    scopus 로고
    • Images in clinical medicine. Pemphigus foliaceus
    • Johnston S, Kennedy C: Images in clinical medicine. Pemphigus foliaceus. N Engl J Med 2005, 353:2589.
    • (2005) N Engl J Med , vol.353 , pp. 2589
    • Johnston, S.1    Kennedy, C.2
  • 48
    • 33748107226 scopus 로고    scopus 로고
    • Rituximab for the treatment of diffuse large B-cell lymphomas
    • Held G, Poschel V, Pfreundschuh M: Rituximab for the treatment of diffuse large B-cell lymphomas. Expert Rev Anticancer Ther 2006, 6:1175-1186.
    • (2006) Expert Rev Anticancer Ther , vol.6 , pp. 1175-1186
    • Held, G.1    Poschel, V.2    Pfreundschuh, M.3
  • 49
  • 50
    • 33746447184 scopus 로고    scopus 로고
    • Rituximab-induced elimination of acquired angioedema due to C1-inhibitor deficiency
    • Levi M, Hack CE, van Oers MH: Rituximab-induced elimination of acquired angioedema due to C1-inhibitor deficiency. Am J Med 2006, 119:e3-e5.
    • (2006) Am J Med , vol.119
    • Levi, M.1    Hack, C.E.2    van Oers, M.H.3
  • 51
    • 33644808958 scopus 로고    scopus 로고
    • A novel series of arylsulfonylthiophene-2-carboxamidine inhibitors of the complement component C1s
    • Subasinghe NL, Travins JM, Ali F, et al.: A novel series of arylsulfonylthiophene-2-carboxamidine inhibitors of the complement component C1s. Bioorg Med Chem Lett 2006, 16:2200-2204.
    • (2006) Bioorg Med Chem Lett , vol.16 , pp. 2200-2204
    • Subasinghe, N.L.1    Travins, J.M.2    Ali, F.3
  • 52
    • 33750991095 scopus 로고    scopus 로고
    • Discovery of highly potent small molecule kallikrein inhibitors
    • Zhang J, Krishnan R, Arnold CS, et al.: Discovery of highly potent small molecule kallikrein inhibitors. Med Chem 2006, 2:545-553.
    • (2006) Med Chem , vol.2 , pp. 545-553
    • Zhang, J.1    Krishnan, R.2    Arnold, C.S.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.